The addition of erlotinib, an epithelial growth factor receptor (EGFR) inhibitor to everolimus, inhibited growth and induced apoptosis further in 4 NF1-derived and 1 sporadic MPNST cell lines as well as the STS26T sporadic MPNST xenograft [172]. This evidence concerns the gene EGFR and malignant peripheral nerve sheath tumor.